top of page

Gary Martin


I believe drug names matter, and I have helped companies develop hundreds of names, including Perjeta®, Spiolto®, Flixabi®, Enbrel®, Celebrex® and Viagra®.


I have written about naming in, and have been covered by, 

The New York Times, Advertising Age, The Boston Globe, BBC News Magazine, LinkedIn Pulse, and NPR Radio.


Reach me via Email, and follow me on LinkedIn and Twitter.

bottom of page